By: Norma Erickson 06 November 2010 Last Tuesday, the SaneVax team sent a letter to Dr. Margaret Hamburg, FDA Commissioner, and Dr. Harold E. Varmus, Director of the National Cancer Institute (NCI), requesting the establishment of a reliable human papillomavirus (HPV) genotyping test to support the national virology-based cervical cancer prevention program for patient care. […]
NCI on Cervical Cancer Prevention and HPV vaccines: What’s a Woman to do?
By: Norma Erickson 31 August 2010 The following is a direct quote from a recently revised copy of “Cervical Cancer Prevention, Health Professional Version,” published by the National Cancer Institute (NCI): “The finding of HPV viral DNA integrated in most cellular genomes of cervical carcinomas supports epidemiologic data linking this agent to cervical cancer however, […]